Details of the Probe-central Interaction Altas
General Information of Experiment
| Probe Name | D5yne | Probe Info | ||||
|---|---|---|---|---|---|---|
| Probe concentration | 5 uM | |||||
| Criteria | Quantification: Probe vs (Probe+Competitor) | |||||
| Quantitative Method |
LFQ
|
|||||
| Competitor Name | DC-LC3IN-D5 | Competitor Info | ||||
| Competitor Concentration | 25 uM | |||||
| In Vivo Experiment Model | Model Type |
|
Living cell | |||
| Derived Tissue |
|
Cervix uteri | ||||
| Disease Model | Endocervical adenocarcinoma [ICD-11:2C77] | |||||
| Model Name | Human endocervical adenocarcinoma cells (HeLa) | |||||
Interaction Altas of This Experiment [1]
Enzyme
| Target ID | Target Name | Binding Ratio | ||||
|---|---|---|---|---|---|---|
| LDTP06333 | Serum paraoxonase/arylesterase 2 (PON2) | 7.5 | ||||
| LDTP05476 | 3-ketodihydrosphingosine reductase (KDSR) | 2.7 | ||||
| LDTP02175 | Epoxide hydrolase 1 (EPHX1) | 2.6 | ||||
| LDTP05623 | Polypeptide N-acetylgalactosaminyltransferase 2 (GALNT2) | 2.0 | ||||
| LDTP03818 | Phosphoglucomutase-1 (PGM1) | 1.9 | ||||
| LDTP03011 | Casein kinase II subunit alpha' (CSNK2A2) | 1.6 | ||||
Transporter and channel
| Target ID | Target Name | Binding Ratio | ||||
|---|---|---|---|---|---|---|
| LDTP06034 | Lysosome membrane protein 2 (SCARB2) | 11.4 | ||||
| LDTP05302 | Interferon-induced transmembrane protein 3 (IFITM3) | 1.6 | ||||
Other
| Target ID | Target Name | Binding Ratio | ||||
|---|---|---|---|---|---|---|
| LDTP11637 | Microtubule-associated proteins 1A/1B light chain 3B (MAP1LC3B) | 100.0 | ||||
| LDTP00632 | Syntaxin-7 (STX7) | 3.8 | ||||
| LDTP12891 | Glycolipid transfer protein (GLTP) | 3.7 | ||||
| LDTP08389 | Syntaxin-12 (STX12) | 2.3 | ||||
| LDTP09787 | Nicastrin (NCSTN) | 1.7 | ||||
| LDTP02108 | Large ribosomal subunit protein P2 (RPLP2) | 1.7 | ||||
| LDTP08904 | Protein jagunal homolog 1 (JAGN1) | 1.6 | ||||
| LDTP11210 | Transmembrane protein 43 (TMEM43) | 1.5 | ||||